Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 8/20 | 0.59 |
| ▸ | CDC25B | P30305 | 8/20 | 0.59 |
| ▸ | CDC25C | P30307 | 6/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | CASP7 | P55210 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.34 |
| ▸ | MAP2K7 | O14733 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13964188 | 0.84 | CDC25A (0.42) | CDC25ACDC25BCDC25CALDH1A1PKM | |
| SCHEMBL9924710 | 0.82 | CDC25A (0.41) | CDC25ACDC25BCDC25CALDH1A1TSHR | |
| SCHEMBL14029275 | 0.81 | CDC25B (0.45) | CDC25ACDC25BCDC25CALDH1A1 | |
| SCHEMBL18510223 | 0.81 | CDC25A (0.44) | CDC25ACDC25BCDC25C | |
| SCHEMBL14029273 | 0.80 | CDC25A (0.69) | CDC25ACDC25BCDC25CNPSR1ALDH1A1 | |
| SCHEMBL18862049 | 0.79 | CDC25A (0.39) | CDC25ACDC25BCDC25CKDM4E | |
| SCHEMBL29433633 | 0.79 | CDC25A (0.41) | CDC25ACDC25BCDC25CALDH1A1PKM | |
| SCHEMBL14015504 | 0.79 | CDC25A (0.43) | CDC25ACDC25BCDC25C | |
| SCHEMBL9946505 | 0.78 | CDC25A (0.38) | CDC25ACDC25BCDC25CALDH1A1KDM4E | |
| SCHEMBL23295801 | 0.78 | FOLH1 (0.44) | CDC25ACDC25BCDC25CGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 266 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120000803-A | Brush-like structure polypeptide drug delivery system and preparation method and application thereof | 中国科学院杭州医学研究所 | 2025-05-16 | — | — | CN | claimed |
| CN-112979881-B | Macromolecules, compositions and methods for enhancing anticancer drug uptake | 南开大学 | 2023-06-27 | — | — | CN | claimed |
| CN-112979881-A | Macromolecule and composition for promoting anticancer drug intake and application thereof in preparing anticancer drugs | 南开大学 | 2021-06-18 | — | — | CN | claimed |
| CN-109999183-B | Nano-clustering enzyme containing hypoxia activated prodrug and preparation method and application thereof | 中国科学技术大学 | 2021-03-09 | — | — | CN | claimed |
| CN-107951839-B | Polyion micelle shielding system with reversible charges and preparation method thereof | 中国科学院长春应用化学研究所 | 2020-05-19 | — | — | CN | claimed |
| EP-4730479-A2 | FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME | Kyoto University (JP) | 2026-04-22 | — | — | EP | disclosed |
| EP-3438208-B1 | THERMOPLASTIC RESIN COMPOSITION, CELLULOSE-REINFORCED THERMOPLASTIC RESIN COMPOSITION, METHOD FOR PRODUCING CELLULOSE-REINFORCED THERMOPLASTIC RESIN COMPOSITION, CELLULOSE-REINFORCED RESIN MOLDED ARTICLE, AND METHOD FOR PRODUCING CELLULOSE-REINFORCED RESIN MOLDED ARTICLE | FURUKAWA ELECTRIC CO LTD (JP) | 2026-01-07 | — | — | EP | disclosed |
| US-20250246685-A1 | FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME | KYOTO UNIVERSITY (JP) | 2025-07-31 | — | — | US | disclosed |
| WO-2025120994-A1 | SECONDARY BATTERY NON-AQUEOUS ELECTROLYTE AND SECONDARY BATTERY PROVIDED WITH SAME | ステラケミファ株式会社 | 2025-06-12 | — | — | WO | disclosed |
| EP-3689973-B1 | MOLDED ARTICLE | FURUKAWA ELECTRIC CO LTD (JP) | 2025-06-11 | — | — | EP | disclosed |
| CN-120000803-A | Brush-like structure polypeptide drug delivery system and preparation method and application thereof | 中国科学院杭州医学研究所 | 2025-05-16 | — | — | CN | disclosed |
| WO-2025095088-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERY, AND SECONDARY BATTERY PROVIDED WITH SAID SOLUTION | ステラケミファ株式会社 | 2025-05-08 | — | — | WO | disclosed |
| WO-2008022309-A2 | POLYCONJUGATES FOR IN VIVO DELIVERY OF POLYNUCLEOTIDES | F. HOFFMANN-LA ROCHE AG (US) | 2008-02-21 | — | — | WO | disclosed |
| US-20070036865-A1 | Endosomolytic Polymers | MIRUS BIO CORPORATION (US) | 2007-02-15 | — | — | US | disclosed |
| US-20060122096-A1 | Reversible modification of amine-containing compounds | Arrowhead Madison Inc. | 2006-06-08 | — | — | US | disclosed |
| US-7019113-B2 | Reversible modification of membrane interaction | MIRUS BIO CORPORATION (US) | 2006-03-28 | — | — | US | disclosed |
| US-20050250683-A9 | Reversible modification of membrane interaction | Arrowhead Madison Inc. | 2005-11-10 | — | — | US | disclosed |
| EP-1506218-A2 | REVERSIBLE MODIFICATION OF MEMBRANE INTERACTION | Mirus Corporation (US) | 2005-02-16 | — | — | EP | disclosed |
| WO-2003100081-A2 | BIOLOGICALLY ACTIVE MALEAMIC ACID DERIVATIVES WITH LABILE AMIDE BONDS | MIRUS CORPORATION (US) | 2003-12-04 | — | — | WO | disclosed |
| US-20030220264-A1 | Reversible modification of membrane interaction | ROZEMA DAVID B (US) | 2003-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060122096-A1 | Reversible modification of amine-containing compounds | BRDT, AADAC, HDAC10 | CDC25A 735/4885CDC25B 538/4885CDC25C 553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.